Origin BioMed

About:

Origin BioMed is a Canadian company that manufactures over-the-counter consumer health products at therapeutic levels.

Website: http://www.originbiomed.com/

Top Investors: Avrio Capital, Purple Angel, NSBI Venture Capital

Description:

Origin BioMed is a Canadian company that manufactures over-the-counter consumer health products at therapeutic levels. The company produces Neuragen, a non-prescriptive topically applied homeopathic drug used to relieve nerve pain caused by various conditions, including diabetic nerve pain, post-shingles pain, and chronic nerve pain. Origin BioMed’s products are available in pharmacies in Canada and the United States, as well as online. It was founded in 2001 and is based in Halifax, Nova Scotia.

Total Funding Amount:

$3.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Halifax, Nova Scotia, Canada

Founded Date:

2001-01-01

Contact Email:

info(AT)originbiomed.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2007-07-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai